Effect of nef-deleted pseudotyped HIV virions bearing an enhanced green fluorescent protein (EGFP) gene in the env on HIV-Sensitive tranformed T cells

Biomedical Research

Volumn 24, Issue 2, 2003, Pages 59-69

  Shinya, Eiji ^a,b   Hidaka, Chizuno ^a   Owaki, Atsuko ^a   Shimizu, Masumi ^a   Li, Yieng ^a   Watanabe, Kuhomi ^a   Watari, Eiji ^a   Hayami, Masanori ^c   Klatzmann, David ^b   Takahashi, Hidemi ^a,c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b SORBONNE UNIVERSITÉ   (France)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE DELETION; GENETIC CODE; HERPES VIRUS SAIMIRI; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SAIMIRIINE HERPESVIRUS 2; VESICULAR STOMATITIS VIRUS;

EID: 3242673345     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.24.59     Document Type: Article

References (45)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A. and Martin, M. A. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
2. Aiken, C. (1997) Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J Virol. 71, 5871-5877.
3. Biesinger, B., Muller-Fleckenstein, I., Simmer, B., Lang, G., Wittmann, S., Platzer, E., Desrosiers, R. C. and Fleckenstein, B. (1992) Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. USA 89, 3116-3119.
4. Brattain, M. G., Fine, W. D., Khaled, F. M., Thompson, J. and Brattain, D. E. (1981) Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 41, 1751-1756.
5. Chazal, N., Singer, G., Aiken, C., Hammarskjold, M. L. and Rekosh, D. (2001) Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J. Virol. 75, 4014-4018.
6. Chesebro, B., Wehrly, K., Nishio, J. and Perryman, S. (1992) Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66, 6547-6554.
7. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J., Richman, D. D. and Guatelli, J. C. (1994) Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68, 2906-2914.
8. Collins, K. L. and Baltimore, D. (1999) HIV's evasion of the cellular immune response. Immunol. Rev. 168, 65-74.
9. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. and Baltimore, D. (1998) HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401.
10. Connor, R. I., Montefiori, D. C., Binley, J. M., Moore, J. P., Bonhoeffer, S., Gettie, A., Fenamore, E. A., Sheridan, K. E., Ho, D. D., Dailey, P. J. and Marx, P. A. (1998) Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Virol. 72, 7501-7509.
11. Cullen, B. R. (1998) HIV-1 auxiliary proteins: making connections in a dying cell. Cell 93, 685-692.
12. Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K. and Desrosiers, R. C. (1992) Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.
13. Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Meriting, M., Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A., Chatfield, C., et al. (1995) Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
14. Enose, Y., Ui, M., Miyake, A., Suzuki, H., Uesaka, H., Kuwata, T., Kunisawa, J., Kiyono, H., Takahashi, H., Miura, T. and Hayami, M. (2002) Protection by intranasal immunization of a nef-deleted, nonpathogenic SHIV against intravaginal challenge with a heterologous pathogenic SHIV. Virology 298, 306-316.
15. Gruber, A., Kan-Mitchell, J., Kuhen, K. L., Mukai, T. and Wong-Staal, F. (2000) Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T- lymphocyte response in vitro. Blood 96, 1327-1333.
16. Hanna, Z., Kay, D. G., Rebai, N., Guimond, A., Jothy, S. and Jolicoeur, P. (1998) Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163-175.
17. Husain, M., Gusella, G. L., Klotman, M. E., Gelman, I. H., Ross, M. D., Schwartz, E. J., Cara, A. and Klotman, P. E. (2002) HIV-1 Nef Induces Proliferation and Anchorage-Independent Growth in Podocytes. J. Am. Soc. Nephrol. 13, 1806-1815.
18. Igarashi, T., Ami, Y., Yamamoto, H., Shibata, R., Kuwata, T., Mukai, R., Shinohara, K., Komatsu, T., Adachi, A. and Hayami, M. (1997) Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine. J. Gen. Virol. 78, 985-989.
19. Johnson, R. P., Lifson, J. D., Czajak, S. C., Cole, K. S., Manson, K. H., Glickman, R., Yang, J., Montefiori, D. C., Montelaro, R., Wyand, M. S. and Desrosiers, R. C. (1999) Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. J. Virol. 73, 4952-4961.
20. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. and Desrosiers, R. C. (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
21. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L. and Desrosiers, R. C. (1995) Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332, 228-232.
22. Kuwata, T., Igarashi, T., Ido, E., Jin, M., Mizuno, A., Chen, J. and Hayami, M. (1995) Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. J. Gen. Virol. 76, 2181-2191.
23. Landau, N. R., Page, K. A. and Littman, D. R. (1991) Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65, 162-169.
24. Lewis, P., Hensel, M. and Emerman, M. (1992) Human immunodeficiency virus infection of cells arrested in the cell cycle. Embo J. 11, 3053-3058.
25. Li, X., Mukai, T., Young, D., Frankel, S., Law, P. and Wong-Staal, F. (1998) Transduction of CD34+ cells by a vesicular stomach virus protein G (VSV- G) pseudotyped HIV-1 vector. Stable gene expression in progeny cells, including dendritic cells. J. Hum. Virol. 1, 346-352.
26. Liu, L. X., Heveker, N., Fackler, O. T., Arold, S., Le Gall, S., Janvier, K., Peterlin, B. M., Dumas, C., Schwartz, O., Benichou, S. and Benarous, R. (2000) Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J. Virol. 74, 5310-5319.
27. McMichael, A. J. and Rowland-Jones, S. L. (2001) Cellular immune responses to HIV. Nature 410, 980-987.
28. Miller, C. J., McChesney, M. B., Lu, X., Dailey, P. J., Chutkowski, C., Lu, D., Brosio, P., Roberts, B. and Lu, Y. (1997) Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71, 1911-1921.
29. Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C. and Feinberg, M. B. (1994) The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113.
30. Mochizuki, H., Schwartz, J. P., Tanaka, K., Brady, R. O. and Reiser, J. (1998) High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72, 8873-8883.
31. Naldini, L., Blomer, U., Gage, F. H., Trono, D. and Verma, I. M. (1996) Efficient transfer, integration, and sustained longterm expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11382-11388.
32. Noguiez-Hellin, P., Meur, M. R., Salzmann, J. L. and Klatzmann, D. (1996) Plasmoviruses: nonviral/viral vectors for gene therapy. Proc. Natl. Acad. Sci. USA 93, 4175-4180.
33. Page, K. A., Landau, N. R and Littman, D. R. (1990) Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64, 5270-5276.
34. Reimann, K. A., Li, J. T., Voss, G., Lekutis, C., Tenner-Racz, K., Racz, P., Lin, W., Montefiori, D. C., Lee-Parritz, D. E., Lu, Y., Collman, R. G., Sodroski, J. and Letvin, N. L. (1996) An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70, 3198-3206.
35. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. and Heard, J. M. (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Medicine 2, 338-342.
36. Steimer, K. S., Puma, J. P., Power, M. D., Powers, M. A., George-Nascimento, C., Stephans, J. C., Levy, J. A., Sanchez-Pescador, R., Luciw, P. A., Barr, P. J., et al. (1986) Differential antibody responses of individuals infected with AIDS- associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology 150, 283-290.
37. Stein, B. S., Gowda, S. D., Lifson, J. D., Penhallow, R. C., Bensch, K. G. and Engleman, E. G. (1987) pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49, 659-668.
38. Takahashi, H., Cohen, J., Hosmalin, A., Cease, K. B., Houghten, R., Cornette, J. L., DeLisi, C., Moss, B., Germain, R. N. and J. A. Berzofsky, J. A. (1988) An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 85, 3105-3109.
39. Toohey, K., Wehrly, K., Nishio, J., Perryman, S. and Chesebro, B. (1995) Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213, 70-79.
40. Ui, M., Kuwata, T., Igarashi, T., Ibuki, K., Miyazaki, Y., Kozyrev, I. L., Enose, Y., Shimada, T., Uesaka, H., Yamamoto, H., Miura, T. and Hayami, M. (1999) Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs. Virology 265, 252-263.
41. Wehrly, K. and Chesebro, B. (1997) p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents. Methods 12, 288-293.
42. Wyand, M. S., Manson, K., Montefiori, D. C., Lifson, J. D., Johnson, R. P. and Desrosiers, R. C. (1999) Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J. Virol. 73, 8356-8363.
43. Yamada, S. and Ohnishi, S. (1986) Vesicular stomatitis virus binds and fuses with phospholipid domain in target cell membranes. Biochemistry 25, 3703-3708.
44. Yasukawa, M., Inoue, Y., Kimura, N. and Fujita, S. (1995) Immortalization of human T cells expressing T-cell receptor gamma delta by herpesvirus saimiri. J. Virol. 69, 8114-8117.
45. Zhao-Emonet, J. C., Boyer, O., Cohen, J. L. and Klatzmann, D. (1998) Deletional and mutational analyses of the human CD4 gene promoter: characterization of a minimal tissue-specific promoter. Biochim. Biophys. Acta 1442, 109-119.